Number of serum samples tested for antibodies to HSV-1 and HSV-2
| Low risk groups | |||||||
|---|---|---|---|---|---|---|---|
| Children | Antenatal | Females* | Males* | Military | STD clinic attenders† | Total | |
| *Blood donors (Brazil, Estonia, India, and Sri Lanka), HIV sentinel surveillance participants (Morocco), adult hospital inpatients (Sri Lanka). | |||||||
| †400/676 (59.2%) of the Sri Lankan STD clinic attenders were men. | |||||||
| All samples collected from Sri Lanka, India, and Moroccan military were collected prospectively. 85%, 24.7%, and 12.6% of Estonia, Moroccan civilians, and Brazil’s samples, respectively, were collected prospectively. The remaining samples were collected in 1998 (6.1%) and 1999 (17.7%), except for those collected on Brazilian children, which were all collected as part of a vaccine study in 1992. | |||||||
| Rio de Janeiro, Brazil | 697 | 399 | 84 | 398 | – | – | 1578 |
| Tartu, Estonia | 1016 | 794 | 574 | 462 | – | – | 2846 |
| Vellore, India | 361 | 990 | 48 | 394 | – | – | 1793 |
| Morocco | 637 | 1663 | – | 621 | 679 | – | 3600 |
| Ragama, Sri Lanka | 433 | 757 | 684 | 1619 | – | 676 | 4169 |
| Total | 3144 | 4603 | 1390 | 3494 | 679 | 676 | 13986 |